Alpha Genesis Expands in to European Research Market
November 14 2017 - 7:15PM
Business Wire
Alpha Genesis, Inc., a leading provider of nonhuman primate
research products and services, has embarked on a further expansion
program to more fully leverage its primate expertise, research
design and integration skills to deliver first-to-market
innovations with European clients.
“Alpha Genesis is a next-generation solution built for today’s
rapidly changing primate research environment. Using our deep
understanding of nonhuman primate solutions and our product
development expertise, Alpha Genesis is positioned to take a
leading role in the development of new product extensions
throughout Europe,” according to a statement from Senior Alpha
Genesis Management. “We are proud of our successful partnership
with leading European academic institutions and the European
pharmaceutical industry and look forward to further assisting these
organizations to adapt to research trends and eliminate potential
disruption in product development.”
Alpha Genesis is an AAALAC-accredited primate research
institution headquartered along the I-95 technology corridor. The
Company features comprehensive infrastructure that enables
immediate availability of a broad range of primate models,
quick-study start, and innovative research and animal management
processes, with flexible and adaptable administrative procedures to
expeditiously manage client study protocol development and
approval. By providing open investigator access, novel research
applications are seamlessly and rapidly integrated in to
pre-clinical studies to deliver unique and innovative research
management capabilities.
For more information about Alpha Genesis, please
visit www.alphagenesisinc.com, or email us directly at
info@alphagenesisinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171114006752/en/
Alpha Genesis, Inc.Dr. Greg
Westergaardgwprimate@alphagenesisinc.com